Skip to content

Clinical study of siddha medicine "Chitramutti Nei" in the treatment of Azhal Pandu(Iron deficiency anemia)

A clinical evaluation of siddha drug "Chitramutti Nei" (Internal) in the treatment of Azhal Pandu (Iron deficiency anemia)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011179
Enrollment
40
Registered
2018-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Azhal Pandu (Iron deficiency anemia)

Interventions

Intervention1: Chitramutti Nei: 4 ml of Chitramutti Nei will be given twice a day along with hot water for a period of 45 days Control Intervention1: Nil: Nil

Sponsors

Ayothidoss Pandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hb level less than normal range, For male : 7-12gms/d1{13-18gms/d1}. For female :7-11gms /d1{11.5-16.5gms/d1}. Patient willing to undergo blood investigation. Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 48days but can opt out of the trial of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: Hypertension.pregnancy and lactation. presence of any associated severe systemic illness.(e.g. CA,RA) Endocrine disorder(Thyroid abnormality,Diabetes mellitus) Cardiac disease.Renal disease.Inherited defects (sickle cell anemia, Thalassemia,Aplastic anemia) Patient not willing to give blood sample. Epilepsy.Worm infestation.

Design outcomes

Primary

MeasureTime frame
Primary outcome is mainly assessed by comparing the pre and post treatment Hemoglobin level, of the trial patient.Timepoint: 45 days

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the following parameters,before and after the treatment.reduction of clinical symptoms.changes in complete blood count.changes in serum ferritin levelTimepoint: 45 days

Countries

India

Contacts

Public ContactDrHVetha Merlin kumari

National institute of Siddha

dr.kmvm@gmail.com9444249798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026